Growth differentiation factor-15 and cardiovascular dysfunction and disease: malefactor or innocent bystander?

被引：25
|
作者：
Taddei, Stefano [1 ]
Virdis, Agostino [1 ]
机构：
[1] Univ Pisa, Dept Internal Med, I-56100 Pisa, Italy
来源：
EUROPEAN HEART JOURNAL | 2010年 / 31卷 / 10期
关键词：
TGF-BETA SUPERFAMILY; INHIBITORY CYTOKINE-1; MYOCARDIAL-INFARCTION; RISK-FACTORS; ATHEROSCLEROSIS; HYPERTENSION; ASSOCIATION; PROTEIN; MARKER; MEMBER;
D O I：
10.1093/eurheartj/ehq077
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1168 / 1171
页数：4
相关论文
共 50 条
  • [21] Preeclampsia and Subsequent Cardiovascular Disease: Villain or Innocent Bystander?
    Maynard, Sharon E.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2013, 8 (07): : 1061 - 1063
  • [22] Circulating growth differentiation factor-15 as a novel biomarker in heart transplant
    Tokavanich, Nithi
    Sinphurmsukskul, Supanee
    Kongruttanachok, Narisorn
    Thammanatsakul, Kanokwan
    Sritangsirikul, Supaporn
    Ariyachaipanich, Aekarach
    Ongcharit, Pat
    Siwamogsatham, Sarawut
    Boonyaratavej, Smonporn
    Puwanant, Sarinya
    ESC HEART FAILURE, 2021, 8 (04): : 3279 - 3285
  • [23] Growth differentiation factor-15 as a biomarker of coronary microvascular dysfunction in ST-segment elevation myocardial infarction
    Tian, Rui
    Wang, Zerui
    Zhang, Shenglin
    Wang, Xiaojun
    Zhang, Yiwen
    Yuan, Jiaquan
    Zhang, Jiajun
    Xu, Feng
    Chen, Yuguo
    Li, Chuanbao
    HELIYON, 2024, 10 (15)
  • [24] Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study
    Lind, Lars
    Wallentin, Lars
    Kempf, Tibor
    Tapken, Heike
    Quint, Anja
    Lindahl, Bertil
    Olofsson, Sylvia
    Venge, Per
    Larsson, Anders
    Hulthe, Johannes
    Elmgren, Anders
    Wollert, Kai C.
    EUROPEAN HEART JOURNAL, 2009, 30 (19) : 2346 - 2353
  • [25] Growth differentiation factor-15 as candidate predictor for mortality in adults with pulmonary hypertension
    Geenen, Laurie W.
    Baggen, Vivan J. M.
    Kauling, Robert M.
    Koudstaal, Thomas
    Boomars, Karin A.
    Boersma, Eric
    Roos-Hesselink, Jolien W.
    van den Bosch, Annemien E.
    HEART, 2020, 106 (06) : 467 - 473
  • [26] Expression and Clinical Role of Growth Differentiation Factor-15 in Ovarian Carcinoma Effusions
    Bock, Annika J.
    Stavnes, Helene T.
    Kempf, Tibor
    Trope, Claes G.
    Berner, Aasmund
    Davidson, Ben
    Staff, Anne Cathrine
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2010, 20 (09) : 1448 - 1455
  • [27] Maternal levels of growth differentiation factor-15 in patients with preeclampsia
    Yuksel, Ilkbal Temel
    Mathyk, Begum Aydogan
    Cetin, Berna Aslan
    Turhan, Ugur
    Okumus, Zihniye Gonca
    Yildirim, Gonca Yetkin
    Acar, Deniz Kanber
    HYPERTENSION IN PREGNANCY, 2018, 37 (04) : 192 - 196
  • [28] Growth/differentiation factor-15: prostate cancer suppressor or promoter?
    Vanhara, P.
    Hampl, A.
    Kozubik, A.
    Soucek, K.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2012, 15 (04) : 320 - 328
  • [29] Growth Differentiation Factor-15 Is a Predictor of Mortality in Critically Ill Patients with Sepsis
    Buendgens, Lukas
    Yagmur, Eray
    Bruensing, Jan
    Herbers, Ulf
    Baeck, Christer
    Trautwein, Christian
    Koch, Alexander
    Tacke, Frank
    DISEASE MARKERS, 2017, 2017
  • [30] Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction
    Khan, Sohail Q.
    Ng, Kelvin
    Dhillon, Onkar
    Kelly, Dominic
    Quinn, Paulene
    Squire, Iain B.
    Davies, Joan E.
    Ng, Leong L.
    EUROPEAN HEART JOURNAL, 2009, 30 (09) : 1057 - 1065
12345